SH3RF2 contributes to cisplatin resistance in ovarian cancer cells by promoting RBPMS degradation.
Gong TT, Liu FH, Xiao Q, Li YZ, Wei YF, Xu HL, Cao F, Sun ML, Jiang FL, Tao T, Ma QP, Qin X, Song Y, Gao S, Wu L, Zhao YH, Huang DH, Wu QJ.
Gong TT, et al. Among authors: tao t.
Commun Biol. 2024 Jan 9;7(1):67. doi: 10.1038/s42003-023-05721-1.
Commun Biol. 2024.
PMID: 38195842
Free PMC article.